Kiora Pharmaceuticals, Inc.
KPRX
$3.32
$0.03090.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.79M | 29.04M | 27.82M | 31.28M | 2.45M |
| Total Receivables | 871.40K | 2.15M | 3.67M | 2.00M | 2.05M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.04M | 175.80K | 195.80K | 182.30K | 233.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 294.60K | 143.80K | 24.40K | -- |
| Total Current Assets | 29.71M | 31.65M | 31.83M | 33.48M | 4.74M |
|
|
|||||
| Total Current Assets | 29.71M | 31.65M | 31.83M | 33.48M | 4.74M |
| Net Property, Plant & Equipment | 62.40K | 135.20K | 145.80K | 107.20K | 115.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 6.69M | 8.80M | 8.81M | 118.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.72M | 34.40K | 36.30K | 43.50K | 8.74M |
| Total Assets | 36.48M | 38.51M | 40.81M | 42.44M | 13.71M |
|
|
|||||
| Total Accounts Payable | 415.60K | 660.40K | 268.60K | 323.10K | 206.30K |
| Total Accrued Expenses | 2.26M | 1.56M | 1.25M | 1.22M | 1.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 23.40K | 33.40K | 42.10K | 47.90K | 47.10K |
| Total Finance Division Other Current Liabilities | 3.31M | 1.27M | 100.00K | -- | -- |
| Total Other Current Liabilities | 3.31M | 1.27M | 100.00K | -- | -- |
| Total Current Liabilities | 6.01M | 3.53M | 1.66M | 1.59M | 1.63M |
|
|
|||||
| Total Current Liabilities | 6.01M | 3.53M | 1.66M | 1.59M | 1.63M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 33.80K | 39.20K | 40.20K | 46.40K | 59.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.68M | 4.91M | 6.02M | 5.90M | 5.91M |
| Total Liabilities | 10.72M | 8.48M | 7.71M | 7.54M | 7.60M |
|
|
|||||
| Common Stock & APIC | 169.42M | 169.26M | 169.09M | 168.69M | 153.27M |
| Retained Earnings | -143.38M | -139.16M | -135.75M | -133.52M | -146.98M |
| Treasury Stock & Other | -282.20K | -75.20K | -245.70K | -264.40K | -182.80K |
| Total Common Equity | 25.76M | 30.03M | 33.10M | 34.90M | 6.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | 25.76M | 30.03M | 33.10M | 34.90M | 6.11M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.76M | 30.03M | 33.10M | 34.90M | 6.11M |
|
|
|||||